Loading company…
Winterthur, Switzerland-based medical technology company making blood flow velocity sensors for interventional cardiology.
Founded in 2012 and headquartered in Winterthur, Switzerland, Medyria AG develops blood flow velocity sensing technology, mainly through its PyCath device used in interventional cardiology. It also sells sensors as OEM components. In July 2025 the company raised CHF 1.5 million in venture funding led by new investor Buenavista Equity Partners. CEO Mauro Sette leads the company. It is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in